MicroPort® announces strategic collaboration on digital subtraction angiography system with Siemens Healthineers

Shanghai, China, June 24, 2020 - Led by MicroPort Scientific Corporation (“MicroPort®”), MicroImaging (Shenzhen) Medical Equipment Co., Ltd. (“MicroImaging”), a subsidiary of MicroPort®, has entered into a framework collaboration agreement with Siemens Healthineers. The two parties will jointly develop Chinese-made digital subtraction angiography systems (“DSAs”).

 

DSAs are used for diagnosis and minimally invasive interventional treatment of the heart, brain and peripheral vessels. The devices visualize blood vessel lesions and assess stenosis. DSAs are widely considered the “gold standard” in angiography due to the clarity of imagery and high definition provided. Despite the importance and high regard of the device, statistics have shown that there are only three DSA units per one million people in China, and approximately 33 units per one million people in the US*. These statistics highlight the need for greater access to DSAs to enable healthcare professionals to offer optimum care to patients and demonstrate the potential for development of the DSA market in China.

 

Speaking of the collaboration, which will see the accelerated progression of manufacturing angiography systems in China, Mr. Zhengrong Pu, Vice President, Advanced Therapies, Greater China, Siemens Healthineers said, “MicroPort® is a leading provider of high-end and innovative medical solutions in China. The collaboration with MicroPort® constitutes a major part of Siemens Healthineers’s China Strategy and will strengthen the presence of Siemens Healthineers in China”. The collaboration will see the two organizations coming together to share their respective innovation and knowledge in imaging equipment and interventional devices.

 

MicroImaging is committed to creating world leading imaging equipment to provide hospitals and patients with accessible and precise diagnosis and treatment solutions and views the partnership as a way in which this commitment can be furthered. Mr. Bo Peng, Chairman of MicroPort® Great China Executive Committee and Chief Marketing Officer, said, “The imaging equipment is not included in the major part of the diversified development strategy of MicroPort®, but this collaboration with Siemens Healthineers marks an important milestone in the implementation of the organization’s medium- and long-term strategy, bringing high-tech healthcare to the doorstep of the patients living in remote areas. The two organizations are committed to working together to optimize and integrate our resources and services to ultimately benefit the lives of patients: the partnership brings together our clinical expertise in the area of vascular health, whilst Siemens brings a wealth of technical acumen. Together we have a shared ambition to propel the high-quality development of China’s medical device industry, so as to provide more Chinese patients with accessible, high-quality and wide-covering integrated therapeutic solutions.”

 

 

About Siemens Healthineers

As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience and digitalizing healthcare.

 

About MicroImaging

The Shenzhen-based MicroImaging is a wholly-owned subsidiary of MicroPort® that focuses on the research and development and manufacturing and supply chain integration of medical imaging equipment used in diagnostics and operating procedures.

 

 

Source

 

*“Market Study of DSA Equipment 2018”, China Association of Medical Equipment